GSK plc announced with effect from 11 March 2024, Dr. Hal Dietz has been appointed a member of the Nominations & Corporate Governance Committee. This appointment is in addition to his role as Chair of the Science Committee and membership of the Chairs' Committee.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,748 GBX | -1.52% | -3.48% | +20.47% |
09:56am | GSK: positive results for depemokimab in severe asthma | CF |
09:50am | GSK's depemokimab asthma treatment meets endpoints in latest trials | AN |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.47% | 91.96B | |
+34.35% | 705B | |
+30.53% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+14.73% | 238B | |
-3.44% | 210B | |
+10.35% | 209B | |
+9.21% | 169B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- GSK plc Appoints Hal Dietz as Member of Nominations & Corporate Governance Committee, Effective 11 March 2024